BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27982131)

  • 1. CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPARα.
    Nakagawa Y; Satoh A; Tezuka H; Han SI; Takei K; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Iwasaki Y; Sone H; Matsuzaka T; Yamada N; Shimano H
    Sci Rep; 2016 Dec; 6():39182. PubMed ID: 27982131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional profiling of PPARα-/- and CREB3L3-/- livers reveals disparate regulation of hepatoproliferative and metabolic functions of PPARα.
    Ruppert PMM; Park JG; Xu X; Hur KY; Lee AH; Kersten S
    BMC Genomics; 2019 Mar; 20(1):199. PubMed ID: 30866796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetes.
    Nakagawa Y; Satoh A; Yabe S; Furusawa M; Tokushige N; Tezuka H; Mikami M; Iwata W; Shingyouchi A; Matsuzaka T; Kiwata S; Fujimoto Y; Shimizu H; Danno H; Yamamoto T; Ishii K; Karasawa T; Takeuchi Y; Iwasaki H; Shimada M; Kawakami Y; Urayama O; Sone H; Takekoshi K; Kobayashi K; Yatoh S; Takahashi A; Yahagi N; Suzuki H; Yamada N; Shimano H
    Endocrinology; 2014 Dec; 155(12):4706-19. PubMed ID: 25233440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR/Cas9 system.
    Nakagawa Y; Oikawa F; Mizuno S; Ohno H; Yagishita Y; Satoh A; Osaki Y; Takei K; Kikuchi T; Han SI; Matsuzaka T; Iwasaki H; Kobayashi K; Yatoh S; Yahagi N; Isaka M; Suzuki H; Sone H; Takahashi S; Yamada N; Shimano H
    Sci Rep; 2016 Jun; 6():27857. PubMed ID: 27291420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
    López-Oliva ME; Garcimartin A; Muñoz-Martínez E
    Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Fatty Acid Oxidation Restrains Systemic Catabolism during Starvation.
    Lee J; Choi J; Scafidi S; Wolfgang MJ
    Cell Rep; 2016 Jun; 16(1):201-212. PubMed ID: 27320917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.
    Kersten S; Seydoux J; Peters JM; Gonzalez FJ; Desvergne B; Wahli W
    J Clin Invest; 1999 Jun; 103(11):1489-98. PubMed ID: 10359558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation.
    Regué L; Minichiello L; Avruch J; Dai N
    J Biol Chem; 2019 Aug; 294(31):11944-11951. PubMed ID: 31209109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
    Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H
    Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice.
    Cotter DG; Ercal B; d'Avignon DA; Dietzen DJ; Crawford PA
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E176-85. PubMed ID: 24865983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic Fasting-Induced PPARα Activity Does Not Depend on Essential Fatty Acids.
    Polizzi A; Fouché E; Ducheix S; Lasserre F; Marmugi AP; Mselli-Lakhal L; Loiseau N; Wahli W; Guillou H; Montagner A
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betaine alleviates hepatic lipid accumulation via enhancing hepatic lipid export and fatty acid oxidation in rats fed with a high-fat diet.
    Xu L; Huang D; Hu Q; Wu J; Wang Y; Feng J
    Br J Nutr; 2015 Jun; 113(12):1835-43. PubMed ID: 25920593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulated expression of PPARalpha target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFalpha.
    Glosli H; Gudbrandsen OA; Mullen AJ; Halvorsen B; Røst TH; Wergedahl H; Prydz H; Aukrust P; Berge RK
    Biochim Biophys Acta; 2005 Jun; 1734(3):235-46. PubMed ID: 15893958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARα axis signalling.
    Shao M; Shan B; Liu Y; Deng Y; Yan C; Wu Y; Mao T; Qiu Y; Zhou Y; Jiang S; Jia W; Li J; Li J; Rui L; Yang L; Liu Y
    Nat Commun; 2014 Mar; 5():3528. PubMed ID: 24670948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice.
    Erol E; Kumar LS; Cline GW; Shulman GI; Kelly DP; Binas B
    FASEB J; 2004 Feb; 18(2):347-9. PubMed ID: 14656998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.
    Badman MK; Pissios P; Kennedy AR; Koukos G; Flier JS; Maratos-Flier E
    Cell Metab; 2007 Jun; 5(6):426-37. PubMed ID: 17550778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
    Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W
    Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
    Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
    Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.